These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6306224

  • 1. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
    Cohen ML, Kurz KD, Schenck KW.
    J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
    [No Abstract] [Full Text] [Related]

  • 2. Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man.
    Ulm EH.
    Drug Metab Rev; 1983 Jul; 14(1):99-110. PubMed ID: 6301792
    [Abstract] [Full Text] [Related]

  • 3. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
    Pang KS, Cherry WF, Terrell JA, Ulm EH.
    Drug Metab Dispos; 1984 Jul; 12(3):309-13. PubMed ID: 6145558
    [Abstract] [Full Text] [Related]

  • 4. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI, Jackson B, McGrath B, Matthews G, Arnolda L.
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro.
    Swanson BN, Hichens M, Mojaverian P, Ferguson RK, Vlasses PH, Dudash M.
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):525-36. PubMed ID: 6276950
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR, Cohen DM, Essenburg AD, Major TC, Mertz TE, Ryan MJ.
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [Abstract] [Full Text] [Related]

  • 11. The chemistry of enalapril.
    Patchett AA.
    Br J Clin Pharmacol; 1984 Apr; 18 Suppl 2(Suppl 2):201S-207S. PubMed ID: 6085275
    [Abstract] [Full Text] [Related]

  • 12. Physiological and pharmacological aspects of angiotensin converting enzyme.
    Fyhrquist F, Grönhagen-Riska C, Forslund T, Hortling L.
    Scand J Urol Nephrol Suppl; 1984 Apr; 79():39-43. PubMed ID: 6089317
    [No Abstract] [Full Text] [Related]

  • 13. Effects of idrapril calcium on tissue angiotensin-converting enzyme in rats.
    Becagli P, Lippi A, Criscuoli M, Breschi MC, Subissi A.
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):27-32. PubMed ID: 7564361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.